NewAmsterdam Pharma
NAMS
19 hedge funds and large institutions have $445M invested in NewAmsterdam Pharma in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
36% more funds holding
Funds holding: 14 → 19 (+5)
23% more capital invested
Capital invested by funds: $362M → $445M (+$82.6M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.21% less ownership
Funds ownership: 41.09% → 40.89% (-0.21%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$2.04M |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.45M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.06M |
| 4 |
Millennium Management
New York
|
+$702K |
| 5 |
DM
Deerfield Management
New York
|
+$701K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$5.33M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.52M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
NAMS Hedge Fund Activity: Q1 2023 in Review
19 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma (NAMS) for Q1 2023, worth a combined $445M — up 23% from $362M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NAMS positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Viking Global Investors, adding an estimated $2.04M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $5.33M sold.
- 19 institutional investors held NewAmsterdam Pharma (NAMS) as of Q1 2023, up from 14 in Q4 2022.
- Funds reported $445M of NewAmsterdam Pharma stock for Q1 2023, up 23% quarter-over-quarter.
- 8 funds opened new NewAmsterdam Pharma positions in Q1 2023 and 3 closed out, a net change of +5 holders.
- The largest NewAmsterdam Pharma buyer in Q1 2023 was Viking Global Investors, an estimated $2.04M added.
- The largest NewAmsterdam Pharma seller in Q1 2023 was Janus Henderson Group, an estimated $5.33M sold.
Based on aggregated 13F filings for Q1 2023.